User login
Treating Epidermal Melasma With a 4% Hydroquinone Skin Care System Plus Tretinoin Cream 0.025%
New-Generation Radiofrequency Technology
Pause for 2-3 months between cryolipolysis treatments
LAS VEGAS – It’s probably best to treat one area during an initial cryolipolysis session and wait "2-3 months to see what clinical benefits you have" before the next treatment, according to Dr. Mathew Avram.
"If patients are going to get another treatment, I want them to be happy with the first one," he said. Cryolipolysis is expensive, and "there are definitely patients who do not respond."
Also, "you’ll get down a little deeper to cells that weren’t reached" during the first treatment if inflammation and dead fat cells are given a chance to dissipate before the next treatment. "If you wait 2 or 3 months, I think you’ll get a better end-result," said Dr. Avram, director of the Dermatology Laser and Cosmetic Center at Massachusetts General Hospital in Boston.
Most patients can expect a small but noticeable difference with the procedure. "It’s not a home run," but it’s helpful for areas "that you can’t really get rid of with diet and exercise," he said at the SDEF Las Vegas Dermatology Seminar.
The study that earned cryolipolysis (CoolSculpting – Zeltiq Aesthetics Inc.) Food and Drug Administration clearance found that one session decreased love-handle fat layer thickness by 22.7% in 32 patients. One side was treated in each patient, with the other side used as a control. Results were assessed by high-resolution ultrasound and histology at 4 months.
"Most people come in for a little bit of protrusion in the lower abdomen. Two to three months later, they’ll see a small but noticeable decrease," said Dr. Avram, who’s also treated gynecomastia, the upper back, and other areas over the past 3 years.
But "this does not compare to liposuction. This is a much more modest amount of fat removal," he said.
CoolSculpting takes about 1-3 hours and does not require close supervision once the cooling device is placed. The procedure is thought to crystalize lipids in subcutaneous fat cells at near-freezing temperatures, causing their death without damaging the skin. Fat "feels like slush underneath the skin" after treatment, and patients can expect some redness, numbness, and bruising where the device was applied.
Overall, it’s "typically very mild – not a very painful treatment." Postprocedure massage may improve clinical results [although] "there are no hard data to show that," Dr. Avram said.
The areas that respond best are "grabbable areas of fat" because the cooling applicator is not contoured to curved areas like the buttocks, though Zeltiq is working to address the problem, he said.
"The posterior upper arms don’t do as well either. Typically both laxity and fat are involved, and sometimes you can get a little problem with the nerve root there," he said.
The procedure does not change skin pigmentation, but rarely patients can experience significant pain 3-7 days following treatment that resolves with no sequelae. Even more rarely, there can be a paradoxical fat increase in the treated area 3-5 months later, Dr. Avram said.
Cold-air urticaria, cryoglobulinemia, and hernia are all contraindications.
SDEF and this news organization are owned by Frontline Medical Communications. Dr. Avram is on the scientific advisory board of Zeltiq and is a paid consultant to the company.
LAS VEGAS – It’s probably best to treat one area during an initial cryolipolysis session and wait "2-3 months to see what clinical benefits you have" before the next treatment, according to Dr. Mathew Avram.
"If patients are going to get another treatment, I want them to be happy with the first one," he said. Cryolipolysis is expensive, and "there are definitely patients who do not respond."
Also, "you’ll get down a little deeper to cells that weren’t reached" during the first treatment if inflammation and dead fat cells are given a chance to dissipate before the next treatment. "If you wait 2 or 3 months, I think you’ll get a better end-result," said Dr. Avram, director of the Dermatology Laser and Cosmetic Center at Massachusetts General Hospital in Boston.
Most patients can expect a small but noticeable difference with the procedure. "It’s not a home run," but it’s helpful for areas "that you can’t really get rid of with diet and exercise," he said at the SDEF Las Vegas Dermatology Seminar.
The study that earned cryolipolysis (CoolSculpting – Zeltiq Aesthetics Inc.) Food and Drug Administration clearance found that one session decreased love-handle fat layer thickness by 22.7% in 32 patients. One side was treated in each patient, with the other side used as a control. Results were assessed by high-resolution ultrasound and histology at 4 months.
"Most people come in for a little bit of protrusion in the lower abdomen. Two to three months later, they’ll see a small but noticeable decrease," said Dr. Avram, who’s also treated gynecomastia, the upper back, and other areas over the past 3 years.
But "this does not compare to liposuction. This is a much more modest amount of fat removal," he said.
CoolSculpting takes about 1-3 hours and does not require close supervision once the cooling device is placed. The procedure is thought to crystalize lipids in subcutaneous fat cells at near-freezing temperatures, causing their death without damaging the skin. Fat "feels like slush underneath the skin" after treatment, and patients can expect some redness, numbness, and bruising where the device was applied.
Overall, it’s "typically very mild – not a very painful treatment." Postprocedure massage may improve clinical results [although] "there are no hard data to show that," Dr. Avram said.
The areas that respond best are "grabbable areas of fat" because the cooling applicator is not contoured to curved areas like the buttocks, though Zeltiq is working to address the problem, he said.
"The posterior upper arms don’t do as well either. Typically both laxity and fat are involved, and sometimes you can get a little problem with the nerve root there," he said.
The procedure does not change skin pigmentation, but rarely patients can experience significant pain 3-7 days following treatment that resolves with no sequelae. Even more rarely, there can be a paradoxical fat increase in the treated area 3-5 months later, Dr. Avram said.
Cold-air urticaria, cryoglobulinemia, and hernia are all contraindications.
SDEF and this news organization are owned by Frontline Medical Communications. Dr. Avram is on the scientific advisory board of Zeltiq and is a paid consultant to the company.
LAS VEGAS – It’s probably best to treat one area during an initial cryolipolysis session and wait "2-3 months to see what clinical benefits you have" before the next treatment, according to Dr. Mathew Avram.
"If patients are going to get another treatment, I want them to be happy with the first one," he said. Cryolipolysis is expensive, and "there are definitely patients who do not respond."
Also, "you’ll get down a little deeper to cells that weren’t reached" during the first treatment if inflammation and dead fat cells are given a chance to dissipate before the next treatment. "If you wait 2 or 3 months, I think you’ll get a better end-result," said Dr. Avram, director of the Dermatology Laser and Cosmetic Center at Massachusetts General Hospital in Boston.
Most patients can expect a small but noticeable difference with the procedure. "It’s not a home run," but it’s helpful for areas "that you can’t really get rid of with diet and exercise," he said at the SDEF Las Vegas Dermatology Seminar.
The study that earned cryolipolysis (CoolSculpting – Zeltiq Aesthetics Inc.) Food and Drug Administration clearance found that one session decreased love-handle fat layer thickness by 22.7% in 32 patients. One side was treated in each patient, with the other side used as a control. Results were assessed by high-resolution ultrasound and histology at 4 months.
"Most people come in for a little bit of protrusion in the lower abdomen. Two to three months later, they’ll see a small but noticeable decrease," said Dr. Avram, who’s also treated gynecomastia, the upper back, and other areas over the past 3 years.
But "this does not compare to liposuction. This is a much more modest amount of fat removal," he said.
CoolSculpting takes about 1-3 hours and does not require close supervision once the cooling device is placed. The procedure is thought to crystalize lipids in subcutaneous fat cells at near-freezing temperatures, causing their death without damaging the skin. Fat "feels like slush underneath the skin" after treatment, and patients can expect some redness, numbness, and bruising where the device was applied.
Overall, it’s "typically very mild – not a very painful treatment." Postprocedure massage may improve clinical results [although] "there are no hard data to show that," Dr. Avram said.
The areas that respond best are "grabbable areas of fat" because the cooling applicator is not contoured to curved areas like the buttocks, though Zeltiq is working to address the problem, he said.
"The posterior upper arms don’t do as well either. Typically both laxity and fat are involved, and sometimes you can get a little problem with the nerve root there," he said.
The procedure does not change skin pigmentation, but rarely patients can experience significant pain 3-7 days following treatment that resolves with no sequelae. Even more rarely, there can be a paradoxical fat increase in the treated area 3-5 months later, Dr. Avram said.
Cold-air urticaria, cryoglobulinemia, and hernia are all contraindications.
SDEF and this news organization are owned by Frontline Medical Communications. Dr. Avram is on the scientific advisory board of Zeltiq and is a paid consultant to the company.
EXPERT ANALYSIS FROM SDEF LAS VEGAS DERMATOLOGY SEMINAR
Flaxseed
Linum usitatissimum, an annual plant native to the eastern Mediterranean and India and better known as flax (or linseed, several decades ago), was cultivated in ancient Egypt and Ethiopia and used for many purposes, including as an ingredient in medicine, soap, and hair products. The oil from the seeds of the plant is thought to possess significant health benefits. Flaxseed oil is one of the richest sources of omega-3 fatty acids, in particular, alpha-linolenic acid (ALA), which represents more than 50% of its total fatty acid content (Br. J. Nutr. 2009;101:440-5; Medical Herbalism: The science and practice of herbal medicine. Healing Arts Press: Rochester, Vt., 2003, p. 57). In addition, flaxseeds are rich in dietary fiber and lignans, which are phytoestrogens with antioxidant properties.
Antioxidant, anti-inflammatory, and antiapoptotic properties have been associated with flaxseed oil and warrant medical consideration. The substantial anti-inflammatory activity of L. usitatissimum has been ascribed to its primary active constituent, ALA (57%), which suppresses arachidonic acid metabolism, thus inhibiting the synthesis of proinflammatory n-6 eicosanoids and reducing vascular permeability (Inflammopharmacology 2010;18:127-36).
In a randomized, double-blind, placebo-controlled application test in 2009, De Spirt et al. studied the cutaneous effects of supplementation with flaxseed or borage oil for 12 weeks in two groups of women (n = 45) aged 18-65 years with sensitive and dry skin. Fifteen women were included in each group, and 15 were randomized to a placebo control group. The placebo group received medium-chain fatty acids. The flaxseed oil included ALA and linoleic acid, and the borage oil contained linoleic and gamma-linolenic acids. ALA contributed to the significant rise in total fatty acids in plasma seen in the flaxseed oil group at weeks 6 and 12. An increase in gamma-linolenic acid was noted in the borage oil group. Erythema, roughness, and scaling were decreased in both treatment groups compared with baseline, while skin hydration was markedly elevated after 12 weeks. In addition, transepidermal water loss was diminished by 10% after 6 weeks in both oil treatment groups, with further reductions after 12 weeks in the flaxseed oil group. The investigators concluded that intervention with dietary lipids can manifest as skin improvements (Br. J. Nutr. 2009;101:440-5).
In 2010, Kaithwas and Majumdar evaluated the anti-inflammatory potential of flaxseed fixed oil against castor oil–induced diarrhea, turpentine oil–induced joint edema, and formaldehyde-induced and complete Freund’s adjuvant (CFA)-induced arthritis in Wistar albino rats. They found that flaxseed oil dose-dependently inhibited the adverse effects of castor oil and turpentine oil as well as CFA, and a significant inhibitory effect was also exerted by flaxseed oil against formaldehyde-induced proliferation of global edematous arthritis. Flaxseed oil also significantly diminished the secondary lesions engendered by CFA by dint of a delayed hypersensitivity reaction. The authors concluded that the significant anti-inflammatory activity imparted by L. usitatissimum fixed oil suggests its therapeutic viability for inflammatory conditions, such as rheumatoid arthritis (Inflammopharmacology 2010;18:127-36).
Recently, de Souza et al. studied the effects on skin wounds in rats of a semisolid formulation of flaxseed oil (1%, 5%, or 10%). The investigators assessed the contraction/re-epithelialization of the wound and resistance to mechanical traction in incisional and excisional models, respectively. They found that the groups treated with flaxseed oil concentrations of 1% or 5% largely started re-epithelialization earlier than the petroleum jelly control group, and achieved 100% re-epithelialization on the 14th day after injury, as compared to 33% of animals in the petroleum jelly group. The investigators concluded that flaxseed oil, at low concentrations, exhibits potential in a solid pharmaceutical preparation, for use in dermal repair (Evid. Based. Complement. Alternat. Med. 2012;2012:270752).
Early in 2012, Tülüce et al. set out to ascertain the antioxidant and antiapoptotic effects of flaxseed oil exerted against ultraviolet C–induced damage in rats. They divided animals into three groups: control, UVC alone, and UVC and flaxseed oil. UVC light exposure lasted for 1 hour twice daily for four weeks in the two exposure groups. In the flaxseed oil group, the oil was administered by gavage prior to each irradiation (4 mL/kg ). The investigators noted that malondialdehyde and protein carbonyl levels were higher in the UVC group than in the controls, but such levels were reduced in the flaxseed oil group compared with the UVC-only group, in skin, lens, and sera. Also, the activities of glutathione peroxidase and superoxide dismutase were found to be higher in the skin, lens, and sera of the flaxseed oil group as compared to the UVC-only group. In addition, retinal apoptosis was lower in the flaxseed group than in the UVC group. The researchers concluded that flaxseed oil may be useful in conferring a photoprotective effect against UVC-induced damage, as manifested in protein carbonylation and reactive oxygen species generation, in rats (Toxicol. Ind. Health. 2012;28:99-107).
Conclusion
Flaxseed oil has gained recent attention for its salutary effects as part of the diet. Rich in omega-3 essential fatty acids and lignans, flaxseed oil has been found to improve fatty acid profiles. Significantly, emerging evidence points to beneficial cutaneous effects derived from dietary use of flaxseed oil. However, more research is necessary to determine whether the beneficial constituents of flaxseed oil can be harnessed in topical products.
Dr. Baumann is in private practice in Miami Beach. 
Linum usitatissimum, an annual plant native to the eastern Mediterranean and India and better known as flax (or linseed, several decades ago), was cultivated in ancient Egypt and Ethiopia and used for many purposes, including as an ingredient in medicine, soap, and hair products. The oil from the seeds of the plant is thought to possess significant health benefits. Flaxseed oil is one of the richest sources of omega-3 fatty acids, in particular, alpha-linolenic acid (ALA), which represents more than 50% of its total fatty acid content (Br. J. Nutr. 2009;101:440-5; Medical Herbalism: The science and practice of herbal medicine. Healing Arts Press: Rochester, Vt., 2003, p. 57). In addition, flaxseeds are rich in dietary fiber and lignans, which are phytoestrogens with antioxidant properties.
Antioxidant, anti-inflammatory, and antiapoptotic properties have been associated with flaxseed oil and warrant medical consideration. The substantial anti-inflammatory activity of L. usitatissimum has been ascribed to its primary active constituent, ALA (57%), which suppresses arachidonic acid metabolism, thus inhibiting the synthesis of proinflammatory n-6 eicosanoids and reducing vascular permeability (Inflammopharmacology 2010;18:127-36).
In a randomized, double-blind, placebo-controlled application test in 2009, De Spirt et al. studied the cutaneous effects of supplementation with flaxseed or borage oil for 12 weeks in two groups of women (n = 45) aged 18-65 years with sensitive and dry skin. Fifteen women were included in each group, and 15 were randomized to a placebo control group. The placebo group received medium-chain fatty acids. The flaxseed oil included ALA and linoleic acid, and the borage oil contained linoleic and gamma-linolenic acids. ALA contributed to the significant rise in total fatty acids in plasma seen in the flaxseed oil group at weeks 6 and 12. An increase in gamma-linolenic acid was noted in the borage oil group. Erythema, roughness, and scaling were decreased in both treatment groups compared with baseline, while skin hydration was markedly elevated after 12 weeks. In addition, transepidermal water loss was diminished by 10% after 6 weeks in both oil treatment groups, with further reductions after 12 weeks in the flaxseed oil group. The investigators concluded that intervention with dietary lipids can manifest as skin improvements (Br. J. Nutr. 2009;101:440-5).
In 2010, Kaithwas and Majumdar evaluated the anti-inflammatory potential of flaxseed fixed oil against castor oil–induced diarrhea, turpentine oil–induced joint edema, and formaldehyde-induced and complete Freund’s adjuvant (CFA)-induced arthritis in Wistar albino rats. They found that flaxseed oil dose-dependently inhibited the adverse effects of castor oil and turpentine oil as well as CFA, and a significant inhibitory effect was also exerted by flaxseed oil against formaldehyde-induced proliferation of global edematous arthritis. Flaxseed oil also significantly diminished the secondary lesions engendered by CFA by dint of a delayed hypersensitivity reaction. The authors concluded that the significant anti-inflammatory activity imparted by L. usitatissimum fixed oil suggests its therapeutic viability for inflammatory conditions, such as rheumatoid arthritis (Inflammopharmacology 2010;18:127-36).
Recently, de Souza et al. studied the effects on skin wounds in rats of a semisolid formulation of flaxseed oil (1%, 5%, or 10%). The investigators assessed the contraction/re-epithelialization of the wound and resistance to mechanical traction in incisional and excisional models, respectively. They found that the groups treated with flaxseed oil concentrations of 1% or 5% largely started re-epithelialization earlier than the petroleum jelly control group, and achieved 100% re-epithelialization on the 14th day after injury, as compared to 33% of animals in the petroleum jelly group. The investigators concluded that flaxseed oil, at low concentrations, exhibits potential in a solid pharmaceutical preparation, for use in dermal repair (Evid. Based. Complement. Alternat. Med. 2012;2012:270752).
Early in 2012, Tülüce et al. set out to ascertain the antioxidant and antiapoptotic effects of flaxseed oil exerted against ultraviolet C–induced damage in rats. They divided animals into three groups: control, UVC alone, and UVC and flaxseed oil. UVC light exposure lasted for 1 hour twice daily for four weeks in the two exposure groups. In the flaxseed oil group, the oil was administered by gavage prior to each irradiation (4 mL/kg ). The investigators noted that malondialdehyde and protein carbonyl levels were higher in the UVC group than in the controls, but such levels were reduced in the flaxseed oil group compared with the UVC-only group, in skin, lens, and sera. Also, the activities of glutathione peroxidase and superoxide dismutase were found to be higher in the skin, lens, and sera of the flaxseed oil group as compared to the UVC-only group. In addition, retinal apoptosis was lower in the flaxseed group than in the UVC group. The researchers concluded that flaxseed oil may be useful in conferring a photoprotective effect against UVC-induced damage, as manifested in protein carbonylation and reactive oxygen species generation, in rats (Toxicol. Ind. Health. 2012;28:99-107).
Conclusion
Flaxseed oil has gained recent attention for its salutary effects as part of the diet. Rich in omega-3 essential fatty acids and lignans, flaxseed oil has been found to improve fatty acid profiles. Significantly, emerging evidence points to beneficial cutaneous effects derived from dietary use of flaxseed oil. However, more research is necessary to determine whether the beneficial constituents of flaxseed oil can be harnessed in topical products.
Dr. Baumann is in private practice in Miami Beach. 
Linum usitatissimum, an annual plant native to the eastern Mediterranean and India and better known as flax (or linseed, several decades ago), was cultivated in ancient Egypt and Ethiopia and used for many purposes, including as an ingredient in medicine, soap, and hair products. The oil from the seeds of the plant is thought to possess significant health benefits. Flaxseed oil is one of the richest sources of omega-3 fatty acids, in particular, alpha-linolenic acid (ALA), which represents more than 50% of its total fatty acid content (Br. J. Nutr. 2009;101:440-5; Medical Herbalism: The science and practice of herbal medicine. Healing Arts Press: Rochester, Vt., 2003, p. 57). In addition, flaxseeds are rich in dietary fiber and lignans, which are phytoestrogens with antioxidant properties.
Antioxidant, anti-inflammatory, and antiapoptotic properties have been associated with flaxseed oil and warrant medical consideration. The substantial anti-inflammatory activity of L. usitatissimum has been ascribed to its primary active constituent, ALA (57%), which suppresses arachidonic acid metabolism, thus inhibiting the synthesis of proinflammatory n-6 eicosanoids and reducing vascular permeability (Inflammopharmacology 2010;18:127-36).
In a randomized, double-blind, placebo-controlled application test in 2009, De Spirt et al. studied the cutaneous effects of supplementation with flaxseed or borage oil for 12 weeks in two groups of women (n = 45) aged 18-65 years with sensitive and dry skin. Fifteen women were included in each group, and 15 were randomized to a placebo control group. The placebo group received medium-chain fatty acids. The flaxseed oil included ALA and linoleic acid, and the borage oil contained linoleic and gamma-linolenic acids. ALA contributed to the significant rise in total fatty acids in plasma seen in the flaxseed oil group at weeks 6 and 12. An increase in gamma-linolenic acid was noted in the borage oil group. Erythema, roughness, and scaling were decreased in both treatment groups compared with baseline, while skin hydration was markedly elevated after 12 weeks. In addition, transepidermal water loss was diminished by 10% after 6 weeks in both oil treatment groups, with further reductions after 12 weeks in the flaxseed oil group. The investigators concluded that intervention with dietary lipids can manifest as skin improvements (Br. J. Nutr. 2009;101:440-5).
In 2010, Kaithwas and Majumdar evaluated the anti-inflammatory potential of flaxseed fixed oil against castor oil–induced diarrhea, turpentine oil–induced joint edema, and formaldehyde-induced and complete Freund’s adjuvant (CFA)-induced arthritis in Wistar albino rats. They found that flaxseed oil dose-dependently inhibited the adverse effects of castor oil and turpentine oil as well as CFA, and a significant inhibitory effect was also exerted by flaxseed oil against formaldehyde-induced proliferation of global edematous arthritis. Flaxseed oil also significantly diminished the secondary lesions engendered by CFA by dint of a delayed hypersensitivity reaction. The authors concluded that the significant anti-inflammatory activity imparted by L. usitatissimum fixed oil suggests its therapeutic viability for inflammatory conditions, such as rheumatoid arthritis (Inflammopharmacology 2010;18:127-36).
Recently, de Souza et al. studied the effects on skin wounds in rats of a semisolid formulation of flaxseed oil (1%, 5%, or 10%). The investigators assessed the contraction/re-epithelialization of the wound and resistance to mechanical traction in incisional and excisional models, respectively. They found that the groups treated with flaxseed oil concentrations of 1% or 5% largely started re-epithelialization earlier than the petroleum jelly control group, and achieved 100% re-epithelialization on the 14th day after injury, as compared to 33% of animals in the petroleum jelly group. The investigators concluded that flaxseed oil, at low concentrations, exhibits potential in a solid pharmaceutical preparation, for use in dermal repair (Evid. Based. Complement. Alternat. Med. 2012;2012:270752).
Early in 2012, Tülüce et al. set out to ascertain the antioxidant and antiapoptotic effects of flaxseed oil exerted against ultraviolet C–induced damage in rats. They divided animals into three groups: control, UVC alone, and UVC and flaxseed oil. UVC light exposure lasted for 1 hour twice daily for four weeks in the two exposure groups. In the flaxseed oil group, the oil was administered by gavage prior to each irradiation (4 mL/kg ). The investigators noted that malondialdehyde and protein carbonyl levels were higher in the UVC group than in the controls, but such levels were reduced in the flaxseed oil group compared with the UVC-only group, in skin, lens, and sera. Also, the activities of glutathione peroxidase and superoxide dismutase were found to be higher in the skin, lens, and sera of the flaxseed oil group as compared to the UVC-only group. In addition, retinal apoptosis was lower in the flaxseed group than in the UVC group. The researchers concluded that flaxseed oil may be useful in conferring a photoprotective effect against UVC-induced damage, as manifested in protein carbonylation and reactive oxygen species generation, in rats (Toxicol. Ind. Health. 2012;28:99-107).
Conclusion
Flaxseed oil has gained recent attention for its salutary effects as part of the diet. Rich in omega-3 essential fatty acids and lignans, flaxseed oil has been found to improve fatty acid profiles. Significantly, emerging evidence points to beneficial cutaneous effects derived from dietary use of flaxseed oil. However, more research is necessary to determine whether the beneficial constituents of flaxseed oil can be harnessed in topical products.
Dr. Baumann is in private practice in Miami Beach. 
CAT-STARTS mnemonic guides Mohs wound closure
SAN DIEGO – Before he proceeds to close a wound following Mohs surgery, Dr. Howard Steinman employs the mnemonic CAT-STARTS to help him select the repair.
A modification of STARTS, Dr. Steinman uses CAT-STARTS to represent the following factors he considers prior to carrying out the repair: first assess the Cosmetic units, Areas of available skin, and Textures of available skin. Then consider closure options: Second intention and Simple (linear) repairs, Transposition flaps, Advancement flaps, Rotation flaps, Tissue interpolation flaps, and Skin grafts.
"Prior to closing, I draw in the surrounding cosmetic units of the face. Once you’ve done that, you should pay attention to the relaxed skin tension lines," Dr. Steinman said at a meeting sponsored by the American Society for Mohs Surgery.
To illustrate, he showed attendees a digital image of a patient’s nasal lesion prior to repair. "I draw in the midline, the side of the nasal dorsum and nasal-jugal lines, and the alar fold," he explained. "Then I look at the skin texture. This case had a mix of sebaceous skin and smooth skin, so I factored that consideration in to my repair."
Candidate wounds for second-intention healing "are small, shallow wounds, usually less than 1 cm in diameter," said Dr. Steinman, who practices dermatology and Mohs surgery in Irving, Tex. "They’re usually less than a half centimeter deep. Second-intention healing is often especially effective for the alar fold and the medial canthus and less effective for the cheeks, chin, and around the lips."
If healing by second intention is not an option, "you want to consider your repair choices, from the simplest to the most complex," he said. Thus, consider simple (linear) repairs. Thereafter, his suggested order of complexity begins with transposition flaps, followed by advancement flaps, rotation flaps, tissue interpolation flaps, and skin grafts.
"The midline of the nose and the midline of the forehead are two of the best places to do linear repairs, as is the cheek and forehead," Dr. Steinman commented. "One thing to remember about straight line repairs is that they cause significant secondary motion perpendicular to the axis of closure. You need to respect that when doing linear repairs near free margins," he added.
If you unable to close a wound in a side-to-side fashion, "a transition flap may be your best option," he continued. "Because rotation flaps require longer, broad incisions, in my view you should often think about an advancement flap as your next choice after transposition flaps in terms of complexity."
Tissue interpolation flaps are reserved "for instances where no local skin flap is a better choice," he said. "The midline forehead flap is excellent for distal nasal defects because you have a broad area of skin and it’s based on a vascular pedicle. Interpolation flaps are two-stage procedures."
He views skin grafts to be a last choice for most wound repairs. "If you do them well and, when needed, laser or abrade them, they often look acceptable, but in my opinion they are the last option for many locations," he said.
Dr. Steinman said that he had no relevant financial conflicts to disclose.
SAN DIEGO – Before he proceeds to close a wound following Mohs surgery, Dr. Howard Steinman employs the mnemonic CAT-STARTS to help him select the repair.
A modification of STARTS, Dr. Steinman uses CAT-STARTS to represent the following factors he considers prior to carrying out the repair: first assess the Cosmetic units, Areas of available skin, and Textures of available skin. Then consider closure options: Second intention and Simple (linear) repairs, Transposition flaps, Advancement flaps, Rotation flaps, Tissue interpolation flaps, and Skin grafts.
"Prior to closing, I draw in the surrounding cosmetic units of the face. Once you’ve done that, you should pay attention to the relaxed skin tension lines," Dr. Steinman said at a meeting sponsored by the American Society for Mohs Surgery.
To illustrate, he showed attendees a digital image of a patient’s nasal lesion prior to repair. "I draw in the midline, the side of the nasal dorsum and nasal-jugal lines, and the alar fold," he explained. "Then I look at the skin texture. This case had a mix of sebaceous skin and smooth skin, so I factored that consideration in to my repair."
Candidate wounds for second-intention healing "are small, shallow wounds, usually less than 1 cm in diameter," said Dr. Steinman, who practices dermatology and Mohs surgery in Irving, Tex. "They’re usually less than a half centimeter deep. Second-intention healing is often especially effective for the alar fold and the medial canthus and less effective for the cheeks, chin, and around the lips."
If healing by second intention is not an option, "you want to consider your repair choices, from the simplest to the most complex," he said. Thus, consider simple (linear) repairs. Thereafter, his suggested order of complexity begins with transposition flaps, followed by advancement flaps, rotation flaps, tissue interpolation flaps, and skin grafts.
"The midline of the nose and the midline of the forehead are two of the best places to do linear repairs, as is the cheek and forehead," Dr. Steinman commented. "One thing to remember about straight line repairs is that they cause significant secondary motion perpendicular to the axis of closure. You need to respect that when doing linear repairs near free margins," he added.
If you unable to close a wound in a side-to-side fashion, "a transition flap may be your best option," he continued. "Because rotation flaps require longer, broad incisions, in my view you should often think about an advancement flap as your next choice after transposition flaps in terms of complexity."
Tissue interpolation flaps are reserved "for instances where no local skin flap is a better choice," he said. "The midline forehead flap is excellent for distal nasal defects because you have a broad area of skin and it’s based on a vascular pedicle. Interpolation flaps are two-stage procedures."
He views skin grafts to be a last choice for most wound repairs. "If you do them well and, when needed, laser or abrade them, they often look acceptable, but in my opinion they are the last option for many locations," he said.
Dr. Steinman said that he had no relevant financial conflicts to disclose.
SAN DIEGO – Before he proceeds to close a wound following Mohs surgery, Dr. Howard Steinman employs the mnemonic CAT-STARTS to help him select the repair.
A modification of STARTS, Dr. Steinman uses CAT-STARTS to represent the following factors he considers prior to carrying out the repair: first assess the Cosmetic units, Areas of available skin, and Textures of available skin. Then consider closure options: Second intention and Simple (linear) repairs, Transposition flaps, Advancement flaps, Rotation flaps, Tissue interpolation flaps, and Skin grafts.
"Prior to closing, I draw in the surrounding cosmetic units of the face. Once you’ve done that, you should pay attention to the relaxed skin tension lines," Dr. Steinman said at a meeting sponsored by the American Society for Mohs Surgery.
To illustrate, he showed attendees a digital image of a patient’s nasal lesion prior to repair. "I draw in the midline, the side of the nasal dorsum and nasal-jugal lines, and the alar fold," he explained. "Then I look at the skin texture. This case had a mix of sebaceous skin and smooth skin, so I factored that consideration in to my repair."
Candidate wounds for second-intention healing "are small, shallow wounds, usually less than 1 cm in diameter," said Dr. Steinman, who practices dermatology and Mohs surgery in Irving, Tex. "They’re usually less than a half centimeter deep. Second-intention healing is often especially effective for the alar fold and the medial canthus and less effective for the cheeks, chin, and around the lips."
If healing by second intention is not an option, "you want to consider your repair choices, from the simplest to the most complex," he said. Thus, consider simple (linear) repairs. Thereafter, his suggested order of complexity begins with transposition flaps, followed by advancement flaps, rotation flaps, tissue interpolation flaps, and skin grafts.
"The midline of the nose and the midline of the forehead are two of the best places to do linear repairs, as is the cheek and forehead," Dr. Steinman commented. "One thing to remember about straight line repairs is that they cause significant secondary motion perpendicular to the axis of closure. You need to respect that when doing linear repairs near free margins," he added.
If you unable to close a wound in a side-to-side fashion, "a transition flap may be your best option," he continued. "Because rotation flaps require longer, broad incisions, in my view you should often think about an advancement flap as your next choice after transposition flaps in terms of complexity."
Tissue interpolation flaps are reserved "for instances where no local skin flap is a better choice," he said. "The midline forehead flap is excellent for distal nasal defects because you have a broad area of skin and it’s based on a vascular pedicle. Interpolation flaps are two-stage procedures."
He views skin grafts to be a last choice for most wound repairs. "If you do them well and, when needed, laser or abrade them, they often look acceptable, but in my opinion they are the last option for many locations," he said.
Dr. Steinman said that he had no relevant financial conflicts to disclose.
EXPERT ANALYSIS FROM A MEETING SPONSORED BY THE AMERICAN SOCIETY FOR MOHS SURGERY
Culture-Conscious Lip Enhancement
Lip enhancement is a commonly performed aesthetic procedure in the United States. However, in the literature, anthropometric measurements defining the ideal lip proportions are computed and reported based on the white face. These proportions do not reflect the ethnic variations in Hispanic, Asian, and black lip dimensions.
In a study in the Journal of Plastic Reconstructive Aesthetic Surgery, Wong et al. evaluated three-dimensional models of male and female white, Chinese, and Korean subjects using surface-imaging technology (2010;63:2032-9). In both the Chinese and Korean patient groups, there were significant differences in lip parameters and lip-projection volumes, compared with whites, thus revealing measurable differences in the Asian lip morphology. Similarly, Hispanics and blacks do not exhibit the common 2/3 to 1/3 lip height proportions that are commonly used to define the "ideal" lip proportions in whites.
Skin of color patients often have full upper and lower lips, often with a 1/2 to 1/2 height ratio. In addition, photodamage and fine rhytids are not as common in these patients. Mandibular retraction in the lower face leads to perioral volume loss and ptosis of the lateral oral commissures, the development of the prejowl sulcus, and loss of lip volume.
Rejuvenation of the lip and perioral area in skin of color patients should involve the symmetry, shape, and projection of the lips in the context of their ethnicity and the structural differences in their faces. The extent and pattern of volume loss in the perioral region and the lower face should also be evaluated and treated. Revolumizing the lower face in conjunction with revolumizing the lips can produce perioral lifting and global lifting of the mouth and lower face.
Lip enhancement in skin of color patients should involve an understanding of both the inherent differences in the perception of beauty in skin of color patients and the differences in the mechanism of aging. Volumizing and recontouring of the perioral region is best approached in the context of what is thought to be aesthetically pleasing based on patient’s culture, ethnicity, and facial structure.
--Lily Talakoub, M.D.
Lip enhancement is a commonly performed aesthetic procedure in the United States. However, in the literature, anthropometric measurements defining the ideal lip proportions are computed and reported based on the white face. These proportions do not reflect the ethnic variations in Hispanic, Asian, and black lip dimensions.
In a study in the Journal of Plastic Reconstructive Aesthetic Surgery, Wong et al. evaluated three-dimensional models of male and female white, Chinese, and Korean subjects using surface-imaging technology (2010;63:2032-9). In both the Chinese and Korean patient groups, there were significant differences in lip parameters and lip-projection volumes, compared with whites, thus revealing measurable differences in the Asian lip morphology. Similarly, Hispanics and blacks do not exhibit the common 2/3 to 1/3 lip height proportions that are commonly used to define the "ideal" lip proportions in whites.
Skin of color patients often have full upper and lower lips, often with a 1/2 to 1/2 height ratio. In addition, photodamage and fine rhytids are not as common in these patients. Mandibular retraction in the lower face leads to perioral volume loss and ptosis of the lateral oral commissures, the development of the prejowl sulcus, and loss of lip volume.
Rejuvenation of the lip and perioral area in skin of color patients should involve the symmetry, shape, and projection of the lips in the context of their ethnicity and the structural differences in their faces. The extent and pattern of volume loss in the perioral region and the lower face should also be evaluated and treated. Revolumizing the lower face in conjunction with revolumizing the lips can produce perioral lifting and global lifting of the mouth and lower face.
Lip enhancement in skin of color patients should involve an understanding of both the inherent differences in the perception of beauty in skin of color patients and the differences in the mechanism of aging. Volumizing and recontouring of the perioral region is best approached in the context of what is thought to be aesthetically pleasing based on patient’s culture, ethnicity, and facial structure.
--Lily Talakoub, M.D.
Lip enhancement is a commonly performed aesthetic procedure in the United States. However, in the literature, anthropometric measurements defining the ideal lip proportions are computed and reported based on the white face. These proportions do not reflect the ethnic variations in Hispanic, Asian, and black lip dimensions.
In a study in the Journal of Plastic Reconstructive Aesthetic Surgery, Wong et al. evaluated three-dimensional models of male and female white, Chinese, and Korean subjects using surface-imaging technology (2010;63:2032-9). In both the Chinese and Korean patient groups, there were significant differences in lip parameters and lip-projection volumes, compared with whites, thus revealing measurable differences in the Asian lip morphology. Similarly, Hispanics and blacks do not exhibit the common 2/3 to 1/3 lip height proportions that are commonly used to define the "ideal" lip proportions in whites.
Skin of color patients often have full upper and lower lips, often with a 1/2 to 1/2 height ratio. In addition, photodamage and fine rhytids are not as common in these patients. Mandibular retraction in the lower face leads to perioral volume loss and ptosis of the lateral oral commissures, the development of the prejowl sulcus, and loss of lip volume.
Rejuvenation of the lip and perioral area in skin of color patients should involve the symmetry, shape, and projection of the lips in the context of their ethnicity and the structural differences in their faces. The extent and pattern of volume loss in the perioral region and the lower face should also be evaluated and treated. Revolumizing the lower face in conjunction with revolumizing the lips can produce perioral lifting and global lifting of the mouth and lower face.
Lip enhancement in skin of color patients should involve an understanding of both the inherent differences in the perception of beauty in skin of color patients and the differences in the mechanism of aging. Volumizing and recontouring of the perioral region is best approached in the context of what is thought to be aesthetically pleasing based on patient’s culture, ethnicity, and facial structure.
--Lily Talakoub, M.D.
Follow AIDET to guide patient expectations
SAN DIEGO – When performing dermatologic surgery, "fulfilling the expectations of patients and their families is the key to satisfaction," Dr. Howard K. Steinman said at a meeting sponsored by the American Society for Mohs Surgery.
"The yin and the yang of keeping patients satisfied involves fulfilling their expectations and satisfying their unmet expectations," Dr. Steinman said. "You have to do both. The trouble is, patient expectations are often unknown, vague, or inaccurate, or they’re irrational and unachievable. These types of expectations are dangerous and often the result of significant dissatisfaction, and unfortunately, litigation and complaints to medical boards."
Examples of nonspecific expectations include remarks such as "I want to look 10 years younger," "I hate my face," "I want to look like this picture," "what do you think I need, doctor?" and "my spouse wants me to have this fixed."
In these instances, expectations need to be modified before treatment, Dr. Steinman emphasized. This is all part of the consultation.
Dr. Steinman, who practices dermatology in Irving, Tex., shared techniques that help him to stay effective, centered, and calm while satisfying patient expectations.
To track these techniques, he advised using the mnemonic AIDET, which he learned during his post as director of dermatologic and skin surgery at Scott & White Clinic in Temple, Tex. AIDET stands for acknowledge, introduce, duration, explanation, and thank you.
The "acknowledge" component of AIDET involves a visible, audible, or tactile sign acknowledging the patient’s presence and an introduction. "Every person entering the exam room or operating room should introduce themselves to the patient," Dr. Steinman said. If loved ones accompany the patient, "I’ll introduce myself to them also, and ask how they’re related. I then go on to explain my role, my background and experience, and my intention to provide excellent service."
Next, provide an estimated time frame for how long the procedure will take. For example, during Mohs surgery cases, "I’ll take the specimen out, but before I leave the room I’ll say, ‘please have a seat in the waiting room. It’s going to be about 45 minutes until your slides are ready’ – even though this usually only takes 20-25 minutes. Overestimate the time so patients don’t become disappointed."
The "explanation" component of the mnemonic is crucial, Dr. Steinman said. He makes it a point to explain what he’s going to do during the procedure and asks the patient if he or she has any questions before he starts. "If the procedure is going to hurt, let the patient know," he said. "Offer to narrate what you’re doing if the patient finds that helpful. Keep the patient informed. Explain all tasks, sounds, smells, processes, and procedures, and have your staff do the same." For example, if the procedure involves cauterizing tissue, Dr. Steinman will tell the patient, "I’m going to start cauterizing. There is going to be a bad smell. You may want to breathe through your mouth."
Finally, thank patients "for the opportunity to care for them, for their time, their patience (if they had to wait), and for choosing you," he said.
Dr. Steinman said that he had no relevant financial conflicts to disclose.
SAN DIEGO – When performing dermatologic surgery, "fulfilling the expectations of patients and their families is the key to satisfaction," Dr. Howard K. Steinman said at a meeting sponsored by the American Society for Mohs Surgery.
"The yin and the yang of keeping patients satisfied involves fulfilling their expectations and satisfying their unmet expectations," Dr. Steinman said. "You have to do both. The trouble is, patient expectations are often unknown, vague, or inaccurate, or they’re irrational and unachievable. These types of expectations are dangerous and often the result of significant dissatisfaction, and unfortunately, litigation and complaints to medical boards."
Examples of nonspecific expectations include remarks such as "I want to look 10 years younger," "I hate my face," "I want to look like this picture," "what do you think I need, doctor?" and "my spouse wants me to have this fixed."
In these instances, expectations need to be modified before treatment, Dr. Steinman emphasized. This is all part of the consultation.
Dr. Steinman, who practices dermatology in Irving, Tex., shared techniques that help him to stay effective, centered, and calm while satisfying patient expectations.
To track these techniques, he advised using the mnemonic AIDET, which he learned during his post as director of dermatologic and skin surgery at Scott & White Clinic in Temple, Tex. AIDET stands for acknowledge, introduce, duration, explanation, and thank you.
The "acknowledge" component of AIDET involves a visible, audible, or tactile sign acknowledging the patient’s presence and an introduction. "Every person entering the exam room or operating room should introduce themselves to the patient," Dr. Steinman said. If loved ones accompany the patient, "I’ll introduce myself to them also, and ask how they’re related. I then go on to explain my role, my background and experience, and my intention to provide excellent service."
Next, provide an estimated time frame for how long the procedure will take. For example, during Mohs surgery cases, "I’ll take the specimen out, but before I leave the room I’ll say, ‘please have a seat in the waiting room. It’s going to be about 45 minutes until your slides are ready’ – even though this usually only takes 20-25 minutes. Overestimate the time so patients don’t become disappointed."
The "explanation" component of the mnemonic is crucial, Dr. Steinman said. He makes it a point to explain what he’s going to do during the procedure and asks the patient if he or she has any questions before he starts. "If the procedure is going to hurt, let the patient know," he said. "Offer to narrate what you’re doing if the patient finds that helpful. Keep the patient informed. Explain all tasks, sounds, smells, processes, and procedures, and have your staff do the same." For example, if the procedure involves cauterizing tissue, Dr. Steinman will tell the patient, "I’m going to start cauterizing. There is going to be a bad smell. You may want to breathe through your mouth."
Finally, thank patients "for the opportunity to care for them, for their time, their patience (if they had to wait), and for choosing you," he said.
Dr. Steinman said that he had no relevant financial conflicts to disclose.
SAN DIEGO – When performing dermatologic surgery, "fulfilling the expectations of patients and their families is the key to satisfaction," Dr. Howard K. Steinman said at a meeting sponsored by the American Society for Mohs Surgery.
"The yin and the yang of keeping patients satisfied involves fulfilling their expectations and satisfying their unmet expectations," Dr. Steinman said. "You have to do both. The trouble is, patient expectations are often unknown, vague, or inaccurate, or they’re irrational and unachievable. These types of expectations are dangerous and often the result of significant dissatisfaction, and unfortunately, litigation and complaints to medical boards."
Examples of nonspecific expectations include remarks such as "I want to look 10 years younger," "I hate my face," "I want to look like this picture," "what do you think I need, doctor?" and "my spouse wants me to have this fixed."
In these instances, expectations need to be modified before treatment, Dr. Steinman emphasized. This is all part of the consultation.
Dr. Steinman, who practices dermatology in Irving, Tex., shared techniques that help him to stay effective, centered, and calm while satisfying patient expectations.
To track these techniques, he advised using the mnemonic AIDET, which he learned during his post as director of dermatologic and skin surgery at Scott & White Clinic in Temple, Tex. AIDET stands for acknowledge, introduce, duration, explanation, and thank you.
The "acknowledge" component of AIDET involves a visible, audible, or tactile sign acknowledging the patient’s presence and an introduction. "Every person entering the exam room or operating room should introduce themselves to the patient," Dr. Steinman said. If loved ones accompany the patient, "I’ll introduce myself to them also, and ask how they’re related. I then go on to explain my role, my background and experience, and my intention to provide excellent service."
Next, provide an estimated time frame for how long the procedure will take. For example, during Mohs surgery cases, "I’ll take the specimen out, but before I leave the room I’ll say, ‘please have a seat in the waiting room. It’s going to be about 45 minutes until your slides are ready’ – even though this usually only takes 20-25 minutes. Overestimate the time so patients don’t become disappointed."
The "explanation" component of the mnemonic is crucial, Dr. Steinman said. He makes it a point to explain what he’s going to do during the procedure and asks the patient if he or she has any questions before he starts. "If the procedure is going to hurt, let the patient know," he said. "Offer to narrate what you’re doing if the patient finds that helpful. Keep the patient informed. Explain all tasks, sounds, smells, processes, and procedures, and have your staff do the same." For example, if the procedure involves cauterizing tissue, Dr. Steinman will tell the patient, "I’m going to start cauterizing. There is going to be a bad smell. You may want to breathe through your mouth."
Finally, thank patients "for the opportunity to care for them, for their time, their patience (if they had to wait), and for choosing you," he said.
Dr. Steinman said that he had no relevant financial conflicts to disclose.
EXPERT ANALYSIS FROM A MEETING SPONSORED BY THE AMERICAN SOCIETY FOR MOHS SURGERY
Broad-Spectrum Moisturizer Effectively Prevents Molecular Reactions to UVA Radiation
Hair Transplantation
There's No Place for 'Dabbling' in Mohs Surgery
SAN DIEGO – If you’re thinking about adding Mohs surgery to your dermatology practice, Dr. Edward Yob recommended that you consider the following question: "Am I willing to commit the time and resources necessary to developing a Mohs practice and do it right?"
Ultimately, your decision "will be based on your experience, how efficient you are, and how interested you are in Mohs surgery," he said at the meeting sponsored by the American Society for Mohs Surgery. "There’s no dabbling in Mohs; you either do it, or you don’t."
He offered the following tips on incorporating Mohs surgery into your existing practice:
• Start small. Allow extra time, be careful in your patient selection, and avoid distractions. "You don’t want to do your first few Mohs cases when you have a very busy general dermatology clinic," advised Dr. Yob, who practices dermatology and Mohs surgery in Tulsa, Okla. "Attention to detail is the key to Mohs surgery."
• Consider the impact on your practice environment. Do you plan to generate Mohs patients from your practice, or will the cases be generated from other referring physicians? What’s your population base, what are the community practice patterns, and what’s the competition like? "Do you have a Mohs surgeon on every other block?" Dr. Yob asked. "And what’s your surgical experience and that of your team? Are you in an area where managed care is going to reimburse you?"
• Be mindful of referral sources. In 1990, when Dr. Yob moved to Oklahoma from Washington, D.C., where he served as an Air Force dermatologist, "there was not a Mohs surgeon on the Eastern side of the state," he recalled. "Primary care physicians are an enormous referral source, especially those who do simple excisions. If they know you’re there to take care of those patients, you’ll build a bond and you’ll have a steady stream of patients to care for."
Dr. Yob emphasized the importance of keeping referring physicians in the loop about the patients they send you. "If another dermatologist sends me a patient and that patient says, ‘While I’m here, do you think you could check out this spot?’ I’ll check with the referring physician first," he explained. "Some of them will say, ‘Take care of whatever the patient needs while they’re there,’ while others will say, ‘Send them back and let me do the biopsy,’ or whatever the case may be. You have to respect that. Ultimately good communication is the key."
Other potential referral sources include colleagues who specialize in the ear, nose, and throat; plastic surgery; general surgery; and ophthalmology. You can also spread the word about your practice by offering to give Mohs-specific lectures to hospital staff or to meetings of church groups or civic groups. In those cases, "emphasize the advantage of Mohs in terms of its high cure rate, the fact that it spares tissue, and the fact that it involves an immediate repair," he said.
• What will your backup support be? If a case becomes troublesome beyond your scope of expertise, can you send the patient to the hospital right away and know that he or she will be taken care of? "What about specialty backup in the form of other Mohs surgeons, or experts in pathology, ENT, plastics, radiation oncology, general surgery, neurosurgery, and urology?" he asked. "You need to be able to take advice from your backups."
• Will you use an in-house tech or a contracted tech? "If you’re only doing Mohs on a limited basis, a contracted tech works pretty well," Dr. Yob said. "How experienced is your tech? How fast are they? Are they eager to learn?"
• Be conservative with patient scheduling. Scheduling patients depends on your volume, how many rooms you have dedicated to Mohs, your surgical experience, and the experience of your team. "If you think one Mohs case will take an hour, schedule the time for 2 hours," Dr. Yob recommended. He takes a complexity-based approach to scheduling in which "1" is a minimally complex case, "2" is a moderately complex case, and "3" is a highly complex case "that is going to take you some time and is going to be tough."
Dr. Yob said that he had no relevant financial conflicts to disclose.
SAN DIEGO – If you’re thinking about adding Mohs surgery to your dermatology practice, Dr. Edward Yob recommended that you consider the following question: "Am I willing to commit the time and resources necessary to developing a Mohs practice and do it right?"
Ultimately, your decision "will be based on your experience, how efficient you are, and how interested you are in Mohs surgery," he said at the meeting sponsored by the American Society for Mohs Surgery. "There’s no dabbling in Mohs; you either do it, or you don’t."
He offered the following tips on incorporating Mohs surgery into your existing practice:
• Start small. Allow extra time, be careful in your patient selection, and avoid distractions. "You don’t want to do your first few Mohs cases when you have a very busy general dermatology clinic," advised Dr. Yob, who practices dermatology and Mohs surgery in Tulsa, Okla. "Attention to detail is the key to Mohs surgery."
• Consider the impact on your practice environment. Do you plan to generate Mohs patients from your practice, or will the cases be generated from other referring physicians? What’s your population base, what are the community practice patterns, and what’s the competition like? "Do you have a Mohs surgeon on every other block?" Dr. Yob asked. "And what’s your surgical experience and that of your team? Are you in an area where managed care is going to reimburse you?"
• Be mindful of referral sources. In 1990, when Dr. Yob moved to Oklahoma from Washington, D.C., where he served as an Air Force dermatologist, "there was not a Mohs surgeon on the Eastern side of the state," he recalled. "Primary care physicians are an enormous referral source, especially those who do simple excisions. If they know you’re there to take care of those patients, you’ll build a bond and you’ll have a steady stream of patients to care for."
Dr. Yob emphasized the importance of keeping referring physicians in the loop about the patients they send you. "If another dermatologist sends me a patient and that patient says, ‘While I’m here, do you think you could check out this spot?’ I’ll check with the referring physician first," he explained. "Some of them will say, ‘Take care of whatever the patient needs while they’re there,’ while others will say, ‘Send them back and let me do the biopsy,’ or whatever the case may be. You have to respect that. Ultimately good communication is the key."
Other potential referral sources include colleagues who specialize in the ear, nose, and throat; plastic surgery; general surgery; and ophthalmology. You can also spread the word about your practice by offering to give Mohs-specific lectures to hospital staff or to meetings of church groups or civic groups. In those cases, "emphasize the advantage of Mohs in terms of its high cure rate, the fact that it spares tissue, and the fact that it involves an immediate repair," he said.
• What will your backup support be? If a case becomes troublesome beyond your scope of expertise, can you send the patient to the hospital right away and know that he or she will be taken care of? "What about specialty backup in the form of other Mohs surgeons, or experts in pathology, ENT, plastics, radiation oncology, general surgery, neurosurgery, and urology?" he asked. "You need to be able to take advice from your backups."
• Will you use an in-house tech or a contracted tech? "If you’re only doing Mohs on a limited basis, a contracted tech works pretty well," Dr. Yob said. "How experienced is your tech? How fast are they? Are they eager to learn?"
• Be conservative with patient scheduling. Scheduling patients depends on your volume, how many rooms you have dedicated to Mohs, your surgical experience, and the experience of your team. "If you think one Mohs case will take an hour, schedule the time for 2 hours," Dr. Yob recommended. He takes a complexity-based approach to scheduling in which "1" is a minimally complex case, "2" is a moderately complex case, and "3" is a highly complex case "that is going to take you some time and is going to be tough."
Dr. Yob said that he had no relevant financial conflicts to disclose.
SAN DIEGO – If you’re thinking about adding Mohs surgery to your dermatology practice, Dr. Edward Yob recommended that you consider the following question: "Am I willing to commit the time and resources necessary to developing a Mohs practice and do it right?"
Ultimately, your decision "will be based on your experience, how efficient you are, and how interested you are in Mohs surgery," he said at the meeting sponsored by the American Society for Mohs Surgery. "There’s no dabbling in Mohs; you either do it, or you don’t."
He offered the following tips on incorporating Mohs surgery into your existing practice:
• Start small. Allow extra time, be careful in your patient selection, and avoid distractions. "You don’t want to do your first few Mohs cases when you have a very busy general dermatology clinic," advised Dr. Yob, who practices dermatology and Mohs surgery in Tulsa, Okla. "Attention to detail is the key to Mohs surgery."
• Consider the impact on your practice environment. Do you plan to generate Mohs patients from your practice, or will the cases be generated from other referring physicians? What’s your population base, what are the community practice patterns, and what’s the competition like? "Do you have a Mohs surgeon on every other block?" Dr. Yob asked. "And what’s your surgical experience and that of your team? Are you in an area where managed care is going to reimburse you?"
• Be mindful of referral sources. In 1990, when Dr. Yob moved to Oklahoma from Washington, D.C., where he served as an Air Force dermatologist, "there was not a Mohs surgeon on the Eastern side of the state," he recalled. "Primary care physicians are an enormous referral source, especially those who do simple excisions. If they know you’re there to take care of those patients, you’ll build a bond and you’ll have a steady stream of patients to care for."
Dr. Yob emphasized the importance of keeping referring physicians in the loop about the patients they send you. "If another dermatologist sends me a patient and that patient says, ‘While I’m here, do you think you could check out this spot?’ I’ll check with the referring physician first," he explained. "Some of them will say, ‘Take care of whatever the patient needs while they’re there,’ while others will say, ‘Send them back and let me do the biopsy,’ or whatever the case may be. You have to respect that. Ultimately good communication is the key."
Other potential referral sources include colleagues who specialize in the ear, nose, and throat; plastic surgery; general surgery; and ophthalmology. You can also spread the word about your practice by offering to give Mohs-specific lectures to hospital staff or to meetings of church groups or civic groups. In those cases, "emphasize the advantage of Mohs in terms of its high cure rate, the fact that it spares tissue, and the fact that it involves an immediate repair," he said.
• What will your backup support be? If a case becomes troublesome beyond your scope of expertise, can you send the patient to the hospital right away and know that he or she will be taken care of? "What about specialty backup in the form of other Mohs surgeons, or experts in pathology, ENT, plastics, radiation oncology, general surgery, neurosurgery, and urology?" he asked. "You need to be able to take advice from your backups."
• Will you use an in-house tech or a contracted tech? "If you’re only doing Mohs on a limited basis, a contracted tech works pretty well," Dr. Yob said. "How experienced is your tech? How fast are they? Are they eager to learn?"
• Be conservative with patient scheduling. Scheduling patients depends on your volume, how many rooms you have dedicated to Mohs, your surgical experience, and the experience of your team. "If you think one Mohs case will take an hour, schedule the time for 2 hours," Dr. Yob recommended. He takes a complexity-based approach to scheduling in which "1" is a minimally complex case, "2" is a moderately complex case, and "3" is a highly complex case "that is going to take you some time and is going to be tough."
Dr. Yob said that he had no relevant financial conflicts to disclose.
EXPERT ANALYSIS FROM A MEETING SPONSORED BY THE AMERICAN SOCIETY FOR MOHS SURGERY


 
 

